Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management.
Sato R, Hasegawa D, Guo S, Nuqali AE, Moreno JEP.
J Intensive Care. 2025 Jan 2;13(1):1. doi: 10.1186/s40560-024-00770-y.
PMID:39748440
Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?
Asfar P.
Intensive Care Med. 2003 Feb;29(2):154-5. doi: 10.1007/s00134-002-1590-1.
PMID:12674117
Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock.
Nguyen NTQ, Doan TNM, Sato K, Tkaczyk C, Sellman BR, Diep BA.
Front Immunol. 2023 Sep 15;14:1260627. doi: 10.3389/fimmu.2023.1260627. eCollection 2023.
PMID:37781371
Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
Cocchi MN, Dargin J, Chase M, Patel PV, Grossestreuer A, Balaji L, Liu X, Moskowitz A, Berg K, Donnino MW.